Eledon Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELDN and other ETFs, options, and stocks.

About ELDN

Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cellular transplant, and for people living with autoimmune and neurodegenerative disease. The firm’s compound in development is AT-1501, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L, also called CD154), a well-validated biological target with broad therapeutic potential. 

CEO
David-Alexandre C. Gros
CEODavid-Alexandre C. Gros
Employees
31
Employees31
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2004
Founded2004
Employees
31
Employees31

ELDN Key Statistics

Market cap
200.96M
Market cap200.96M
Price-Earnings ratio
-1.15
Price-Earnings ratio-1.15
Dividend yield
—
Dividend yield—
Average volume
176.34K
Average volume176.34K
High today
$3.41
High today$3.41
Low today
$3.27
Low today$3.27
Open price
$3.38
Open price$3.38
Volume
131.75K
Volume131.75K
52 Week high
$5.54
52 Week high$5.54
52 Week low
$1.91
52 Week low$1.91

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.